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Abstrak
Latar belakang: Demam tifoid menduduki peringkat ke tiga dari 10 besar penyakit terbanyak pada pasien 
rawat inap di rumah sakit (RS) di Indonesia pada tahun 2010. Selain itu terdapat peningkatan resistensi 
dan kasus-kasus karier, dan relaps. Penelitian ini menyajikan hasil analisis data tentang penggunaan 
antibiotik pada pasien tifoid dewasa rawat inap di suatu RS di Indonesia. 
Metode: Data penelitian diekstrak dari rekam medik pasien tifoid dewasa yang dirawat inap di RS PMI 
Bogor periode Juli-Desember 2012. Analisis dilakukan dengan kualitatif (DU90%) dan kuantitatif (DDD/
shr) dengan menggunakan metode ATC/DDD. 
Hasil: Dari 459 pasien tifoid dewasa rawat inap diperoleh DDD/shr pasien tifoid dewasa rawat inap yang 
menggunakan antibiotik selama dari Juli sampai Desember  2012  sebesar  6,35 DDD/shr. Seftriakson 
merupakan antibiotika yang dipakai tertinggi yang setara 4,10 DDD/shr, yang berarti bahwa  di antara 
100 pasien tifoid, 4 pasien memakai seftriakson 2 g setiap hari. Selanjutnya, obat pada segmen 10% lebih  
banyak dibandingkan pada segmen 90%. Di antara 26 jenis antibiotika, 7 jenis di antaranya termasuk pada 
segmen DU 90% yaitu seftriakson (64,54%); levofloksasin (13,90%); ciprofloksasin (3,57%); meropenem 
(2,80%); metronidazol (2,52%); ampisilin-sulbaktam (1,65%); dan sefditoren pivoksil (1,60%).
Kesimpulan: Antibiotik seftriakson yang paling banyak digunakan pada perawatan tifoid pasien dewasa 
rawat inap di rumah sakit. (Health Science Indones 2014;1:40-3) 
Kata kunci: antibiotik, tifoid, ATC/DDD, DU 90%
Abstract
Background: Typhoid fever was the third ranked disease among the top 10 diseases in hospitalized 
patients in Indonesia in 2011. There were increased drug resistance, increased number of carrier, and 
number of relapse cases. This study aimed to analyze the use of antibiotics in hospitalized adult typhoid 
patients in a hospital in Indonesia. 
Methods: The data were extracted from medical records of drug use in adult typhoid patients hospitalized 
in the Indonesian Red Cross Hospital in Bogor (West Java) during the period of July to December 2012. The 
analysis for typhoid was qualitatively (DU90%) and quantitatively (DDD /hbd) using ATC/DDD method.
Results: From 459 typhoid patients, the total use of antibiotics in hospitalized adult typhoid patients 
during the period of July to December 2012 was 6.35 DDD/hbd. The use of ceftriaxone had the highest 
DDD/hbd which was equal to 4.10 DDD/hbd. This meant out of 100 typhoid patients, 4 patients received 
2 g ceftriaxone per day. Ceftriaxone was given in injection form. Furthermore, there were more drugs in 
segment 10% than 90% segment. From 26 types of antibiotics, 7 were included in the DU 90% segment 
which were ceftriaxone (64.54%); levofloxacin (13.90%); ciprofloxacin (3.57%); meropenem (2.80%); 
metronidazole (2.52%); ampicillin-sulbactam (1.65%); cefditoren pivoxil (1.60%).
Conclusion: Ceftriaxone was the most widely used antibiotics in the treatment of hospitalized  adult 
typhoid patients in a hospital in Indonesia. (Health Science Indones 2014;1:40-3) 
Key words: antibiotics, typhoid, ATC/DDD, DU 90%
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The Indonesian health profile data of 2010 showed 
that typhoid and paratyphoid fever ranked in the top 
10 diseases of hospitalized patients in Indonesia.1 
Case studies at a large hospital in Indonesia showed 
suspected typhoid cases had been increasing from 
year to year with an average morbidity of 500/100000 
population and 0.6% to 5% mortality.2 The 2007 
Indonesian Basic Health Research (Riskesdas) 
data showed that the average prevalence of clinical 
typhoid of 1.6% (range: 0.3% to 3%) nationally.3 
At present, problems include, increased resistance 
to commonly used drugs and increased number of 
career or relapsed typhoid cases.2 At this time, the 
first line antibiotic for hospitalized adult typhoid 
patients in Indonesia is ceftriaxone.4
A 2004 study a hospital in Yogyakarta (Java) showed 
that in treating typhoid fever patients there were: 38.7% 
excessive (over) prescribing, 31.8% under prescribing, 
61.875% multiple prescribing, 53.8% incorrect 
prescribing, and 46.2% extravagant prescribing.5 Apart 
from the effects and side-effects of therapy, the use of 
inappropriate drugs is a waste and will increase hospital 
costs and reduce the quality of hospital services.6 
From these issues, the use of antibiotics in hospitalized 
adult typhoid patients needed to be qualitatively 
(Drug Utilization 90% / DU90%) identified to 
determine the 90% types of drugs most commonly 
used and also quantitatively identified (Defined 
Daily Dose/100 days bed or DDD/hbd) to determine 
the daily maintenance dose which is assumed to be 
the average for major indications in the treatment 
of adult patients per hundred patient day using the 
Anatomical Therapeutic Chemical methods and 
Defined Daily Dose (ATC/DDD).7,8
This study aimed to evaluate antibiotics use in hospitalized 
adult typhoid patients qualitatively (DU90%) and quan-
titatively (DDD/hbd) using ATC/DDD method.
METHODS
The study was conducted at the Indonesia Red 
Cross Hospital in Bogor (West Java). The data were 
extracted from all the medical records of hospitalized 
adult patients diagnosed with typhoid from July to 
December 2012. There were 459 patients obtained 
from the medical records.
Medical records of patients with incomplete drug 
data recording and with severe co-morbidities who 
required care in the intensive care unit (ICU) were 
excluded. Data collected included primary diagnosis 
of patients and their co-morbid diseases, drug name 
(either trademarks or generic name), drug dosage 
form, route of administration, dosage, and the 
amount of drug administered, total length of stay 
for typhoid patient in 2012. Samples were patient 
medical records of hospitalized adult typhoid with 
complete data on drugs. 
Data on drugs were analyzed using the ATC/DDD 
method to get an overview of drug use. Data on 
drugs were then traced by name for the active 
substances then searched for ATC codes and DDD 
values  through the WHO website. Values  obtained 
were then calculated for DDD/hbd and DU 90%.
RESULTS 
In general, the total use of antibiotics in hospitalized 
typhoid patients in the period July to December 2012 
amounted to 6.35 DDD/hbd. Table 1 showed that 
ceftriaxone had the highest DDD/hbd which was 4.10 
DDD/hbd. This meant out of 100 typhoid patients, 4 
patients received daily ceftriaxone of 2 g per day. The 
dosage form of ceftriaxone was as an injection.
Table 2 showed there were more drug items in segment 
10% than in segment 90%. From 26 types of antibiotics, 
7 types of antibiotics were included in the DU 90% 
segment namely, ceftriaxone (64.54%); levofloxacin 
(13.90%); ciprofloxacin (3.57%); meropenem (2.80%); 
metronidazole (2.52%); ampicillin-sulbactam (1.65%); 
and cefditoren pivoxil (1.60%).
Table 1. DDD/hbd profile  of 10 most widely used antibiotics
Code ATC Active substance DDD/shr
J01DD04 Ceftriaxone 4.10
J01MA12 Levofloxacin 0.88
J01MA02 Ciprofloxacin 0.23
J01DH02 Meropenem 0.18
J01XD01 Metronidazol 0.16
J01CR01 Ampicillin-sulbactam 0.10
J01DD16 Cefditoren pivoxil 0.10
J01DD08 Cefixime 0.09
J01DE02 Cefpirom 0.08
J01XX01 Fosfomycin 0.07
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Table 2. DU 90% profile of  antibiotics  
ATC Code Antibiotics % % cumulative
J01DD04 Ceftriaxone 64.39 64.39
J01MA12 Levofloxacin 13.87 78.26
J01MA02 Ciprofloxacin 3.56 81.82
J01DH02 Meropenem 2.80 84.61
J01XD01 Metronidazol 2.51 87.12
J01CR01 Ampicillin-Sulbactam 1.65 88.77
J01DD16 Cefditoren pivoxil 1.59 90.36
J01DD08 Cefixime 1.40 91.76
J01DE02 Cefpirom 1.28 93.04
J01XX01 Sodium Fosfomycin 1.08 94.11
J01FA10 Azithromycin 0.93 95.04
J01DE01 Cefepim 0.86 95.90
J01GB03 Gentamycin 0.75 96.65
J01DH51 Imipenem 0.71 97.36
J01DD02 Ceftazidime 0.70 98.06
J01DD12 Sefoperazon 0.63 98.69
J01DD62
Sodium sefoperazon-
sulbactam 0.38 99.07
J01GA01 Streptomycin 0.23 99.30
J01CA04 Amoxicillin 0.18 99.47
J01DD01 Cefotaxim 0.15 99.62
J01DB05 Cefadroxil 0.10 99.73
J01CR02
Amoxicillin-clavulanic 
acid 0.08 99.80
J01EE01
Trimetoprim-
sulfamethoxazol 0.08 99.88
J01FA01 Erythromycin 0.05 99.93
J01DB01 Cefalexin 0.04 99.97
J01FA02 Spiramicyn 0.03 100.00
DISCUSSION
From the profile data for DDD/hbd antibiotics 
obtained, the highest use of ceftriaxone for typhoid 
was 4.10 DDD/hbd. In 2006, the general use of 
ceftriaxone in the hospital was 24.627 DDD/hbd for 
all cases of the disease.9 This was consistent with 
the data obtained in 2011 from the dr. M. Djamil 
Municipal Hospital in Padang (West Sumatra), 
where the highest DDD/hbd was for ceftriaxone, 
with a value of 38.955 DDD/hbd.10 In 2006, the 
DU in segment 90% for the treatment of typhoid 
in the hospital or DDD/hbd ceftriaxone was 24.627 
DDD/hbd. Ceftriaxone was used for the treatment of 
various infectious diseases, the percentage of use for 
ceftriaxone was 4.10 DDD/hbd for the treatment of 
typhoid in the hospital which was 16, 65% of the total 
use of ceftriaxone. The high use of ceftriaxone as 
antibiotic in the treatment of typhoid was supported 
by the high incidence of typhoid in the hospital. 
Therefore, the drug should always be available of in 
the hospital pharmacy.
There were 7 kinds of antibiotics included in DU 
90% segmen from total of 26 kinds of antibiotics. 
Ceftriaxone had the highest percentage with 
64.54%. In 2006, ceftriaxone was also included 
in the three major segments of DU 90% with the 
highest percentage of 11.67%.9 It showed that the 
trend for ceftriaxone usage was still high in this 
hospital. In the Muhammadiyah Hospital Palembang 
(South Sumatera), ceftriaxone also became the most 
preferred antibiotic for typoid (30.77%).11 
In the 2013 Indonesian Typhoid Fever Disease Control 
Guidelines, ceftriaxone was the first-line antibiotics 
for hospitalized adult patients, while chloram penicol 
become first-line therapy for outpatients. Chlo-
ramphenicol had disadvantages such as the availability 
for a sufficient period of time, which can quite often 
lead to carrier and relapse. While ceftriaxone has the 
advantages, such as quickly lower body temperature, 
short duration of administration,  can be used as a 
single dose, and safe enough for children.4 A study 
in 2012 by Juwita et al found that in Banjarmasin 
(South Kalimantan) hospitals, in vitro sensitivity 
testing of Salmonella typhi to antibiotics, showed 
that S. Typhi was still sensitive to chloramphenicol 
and trimetoprim-sulfametoxazol, whereas it was 
resistant to amoxicillin.12 Each choice of antibiotic 
use for typhoid should be considered carefully in 
terms of efficacy, level of sensitivity in each region, 
price, as well as side effects, and each patient should 
be evaluated in detail on the factors associated.2
Antibiotics used for treatment of typhoid that 
were in the 10% DU segment should be replaced 
by antibiotics that were included in the 90% DU 
segment. Cefotaxim, ceftazidime, and cefoperazon 
should be replaced by ceftriaxone, which is still in the 
same third-generation cephalosporin class. The use of 
imipenem should be replaced with meropenem which 
is still in the same carbapenem class, while the use of 
cefepim could be replaced with cefpirom that is still 
in the same fourth-generation cephalosporin class. 
This reduction is expected to be more effectively in 
terms of cost-effectiveness and the variety of drugs in 
a hospital formulary can be decreased. 
From 26 kinds of antibiotics used for the treatment 
of typhoid, there were 17 kinds of antibiotics 
included in the Indonesia National Formulary which 
is used in the Universal Health Coverage (UHC), 
including ceftriaxone, levofloxacin, ciprofloxacin, 
meropenem, metronidazol, cefixime, azithromycin, 
cefepim, gentamycin, ceftazidime, cefoperazone, 
streptomycin, cefotaxim, cefadroxil, amoxicillin, 
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trimetoprim-sulfamethoxazol, and cefalexin. The 
Indonesian National Formulary is a list of selected 
drugs which are required and should be available 
at health facilities.13 Ceftriaxone as the first line-
therapy for hospitalized typhoid cases has already 
been included in Indonesian National Formulary.
This study has several limitations, interviews with 
patients about the symptoms of disease or physicians 
about the medical consideration on the selection of 
therapy were not conducted. The bacterial culture 
results were not check, so diagnosis was taken 
as stated in the medical records. Data patterns of 
microbes and microbial resistance patterns of S. 
typhi and S. paratyphi were not obtained, so the 
appropriateness of antibiotics to microbial resistance 
could not be assessed. 
To support the treatment of typhoid, hospitals need 
to have data pattern on microbes and microbial 
resistance patterns of typhoid to evaluate the 
accuracy of the use of antibiotics in the treatment, 
and avoid the occurrence of microbial resistance. 
Each antibiotics for typhoid should be considered 
carefully in terms of efficacy, sensitivity of the 
bacteria in each region, price, as well as side effects. 
In conclusion, antibiotics that are most widely used 
in the treatment of typhoid in Indonesia Red Cross 
Hospital in Bogor was ceftriaxone with 4.10 DDD/
hbd and DU 90% value of 64.54%. Many variations 
in the use of  third–generation cephalosporin class 
antibiotics, was less efficient for the hospital.
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